Pfizer, Alibaba, Amazon, Merck unite to fight COVID-19 fraud

Criminal investigators in the US Homeland Security Investigations’ (HSI) National Intellectual Property Rights Coordination Center have partnered with Pfizer, 3M, Citi, Alibaba, Amazon and Merck & Co to combat fraud and other illegal activity related to COVID-19.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Medtech

Therabody launches infringement charge against TJ Maxx, others

15 March 2022 Therabody has sued TJ Maxx’s parent company, alongside five “unauthorised” Amazon resellers for patent and trademark infringement, claiming they sell “knockoff” massage gun products.

Big Pharma

Counterfeiters ‘exploiting demand’ for COVID-19 vaccines

27 April 2021 Pfizer has discovered counterfeit versions of its COVID-19 vaccine in Mexico and Poland, prompting governments to reassure the public over the safety of vaccine supply chains.

Asia-Pacific

Australia investigates counterfeit N95s in hospitals

26 May 2020 The Australian government has ordered an investigation into the sale of counterfeit face masks in the country, following warnings from health experts and local media reports over the prevalence of fake equipment.

More features

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

Barnes & Thornburg reveals five new IP leaders

Pfizer, Alibaba, Amazon, Merck unite to fight COVID-19 fraud

More on this story

Editor's picks

Editor's picks

More features